Effects of lipopeptide biosurfactants on clinical strains of Malassezia furfur growth and biofilm formation

• Published in: Medical mycology (Oxford) Vol. 59; no. 12; pp. 1191 - 1201
• Main Authors: da Silva, Gabrielly Oliveira, Farias, Bárbara Cibelle Soares, da Silva, Renally Barbosa, Teixeira, Edson Holanda, Cordeiro, Rossana de Aguiar, Hissa, Denise Cavalcante, Melo, Vânia Maria Maciel
• Format: Journal Article
• Language: English
• Published: England Oxford University Press 03-12-2021
• Subjects: Animals; Antifungal Agents - pharmacology; Biofilms; Lipopeptides - pharmacology; Malassezia; Mice; Microbial Sensitivity Tests - veterinary; antifungal; dermatitis; cytotoxicity; biosurfactant; minimum inhibitory concentration
• ISSN: 1369-3786; 1460-2709
• DOI: 10.1093/mmy/myab051

Abstract
Lipopeptide biosurfactants (LBs) are biological molecules with low toxicity that have aroused growing interest in the pharmaceutical industry. Their chemical structure confers antimicrobial and antibiofilm properties against different species. Despite their potential, few studies have demonstrated their capability against Malassezia spp., commensal yeasts which can cause dermatitis and serious infections. Thus, the aim of this study was to evaluate the antifungal activity of biosurfactants produced by new strains of Bacillus subtilis TIM10 and B. vallismortis TIM68 against M. furfur and their potential for removal and inhibition of yeast biofilms. Biosurfactants were classified as lipopeptides by FTIR, and their composition was characterized by ESI-Q-TOF/MS, showing ions for iturin, fengycin, and surfactin, with a greater abundance of surfactin. Through the broth microdilution method, both biosurfactants inhibited the growth of clinical M. furfur strains. Biosurfactant TIM10 showed greater capacity for growth inhibition, with no statistical difference compared to those obtained by the commercial antifungal fluconazole for M. furfur 153DR5 and 154DR8 strains. At minimal inhibitory concentrations (MIC-2), TIM10 and TIM68 were able to inhibit biofilm formation, especially TIM10, with an inhibition rate of approximately 90%. In addition, both biosurfactants were able to remove pre-formed biofilm. Both biosurfactants showed no toxicity against murine fibroblasts, even at concentrations above MIC-2. Our results show the effectiveness of LBs in controlling the growth and biofilm formation of M. furfur clinical strains and highlight the potential of these agents to compose new formulations for the treatment of these fungi.